Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KalVista Pharmaceuticals, Inc. (“KalVista” or the “Company”) (NASDAQ: KALV). Such...
-
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Eve Holding, Inc. (“”Eve” or the “Company”) (NYSE: EVEX). Such investors are advised to...
-
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Honda Motor Co., Ltd. (“Honda” or the “Company”) (NYSE: HMC). Such investors are advised...
-
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD). Such investors are advised...
-
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sunlight Financial Holdings Inc. (“Sunlight” or the “Company”) (NYSE: SUNL). Such...
-
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olaplex Holdings, Inc. (“Olaplex” or the “Company”) (NASDAQ: OLPX). Such investors are...
-
NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the Supreme Court of the State of New York County of New York: Commercial Division has approved the following announcement of...
-
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (“Centessa” or the “Company”) (NASDAQ: CNTA) and...
-
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI). Such...
-
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the “Company”) (NYSE: CMP). Such...